Trial intelligence / Profile preview

Impact of Stannous Fluoride Toothpaste on Quality of Life in Dentine Hypersensitivity

NCT02752958Completed

Sponsor
GSK
Start
May 2016
Primary completion
Feb 2017
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Open-label, single-arm trial of stannous fluoride in dentin hypersensitivity (DH), sponsored by GSK. Primary endpoints: Dentine Hypersensitivity Experience Questionnaire Total Score at 24 weeks, Dentine Hypersensitivity Experience Questionnaire Restrictions Domain Score at 24 weeks and 9 more. Started May 2016; status: completed.

02

Drugs

stannous fluoride
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT02752958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02752958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call